Literature DB >> 33383144

Plumbagin induces Ishikawa cell cycle arrest, autophagy, and apoptosis via the PI3K/Akt signaling pathway in endometrial cancer.

Xiangsheng Zhang1, Huan Kan2, Yun Liu3, Wu Ding4.   

Abstract

Plumbagin (PLB) is a naphthoquinone endowed with potential medicinal properties, including anticancer activities. We evaluated the effects of PLB on the viability, cell cycle, autophagy, and apoptosis of endometrial carcinoma Ishikawa cells. The proliferation of cells was significantly inhibited by PLB at 0, 8, 10, and 12 μM. By up regulating the expression of p53 and p21, PLB could block the cell cycle in G2/M phase and down regulate cyclin dependent kinase. The apoptosis in the cancer cells was characterized by noticeable chromatin edge collection, nuclear membrane expansion, and vacuolization. PLB could significantly induce autophagy in cells, and its inhibition ability and apoptosis induction were weakened by the autophagy inhibitor SBI-0206965. Our study suggested that PLB may exert anticancer effects by abrogating PI3K/Akt pathway, which recommends it as a promising future phytotherapeutic candidate for EC treatment.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Apoptosis; Autophagy; Cell cycle; Ishikawa; Plumbagin

Mesh:

Substances:

Year:  2020        PMID: 33383144     DOI: 10.1016/j.fct.2020.111957

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  9 in total

1.  Macamide B Pretreatment Attenuates Neonatal Hypoxic-Ischemic Brain Damage of Mice Induced Apoptosis and Regulates Autophagy via the PI3K/AKT Signaling Pathway.

Authors:  Xiaoxia Yang; Mengxia Wang; Qian Zhou; Yanxian Bai; Jing Liu; Junhua Yang; Lixia Li; Guoying Li; Li Luo
Journal:  Mol Neurobiol       Date:  2022-02-22       Impact factor: 5.590

2.  In silico prediction of parkinsonian motor deficits-related neurotoxicants based on the adverse outcome pathway concept.

Authors:  Hung-Lin Kan; Chun-Wei Tung; Shao-En Chang; Ying-Chi Lin
Journal:  Arch Toxicol       Date:  2022-09-29       Impact factor: 6.168

3.  Exploration of the Effect and Potential Mechanism of Echinacoside Against Endometrial Cancer Based on Network Pharmacology and in vitro Experimental Verification.

Authors:  Wan Shu; Ziwei Wang; Rong Zhao; Rui Shi; Jun Zhang; Wei Zhang; Hongbo Wang
Journal:  Drug Des Devel Ther       Date:  2022-06-16       Impact factor: 4.319

4.  The Effectiveness of Isoplumbagin and Plumbagin in Regulating Amplitude, Gating Kinetics, and Voltage-Dependent Hysteresis of erg-mediated K+ Currents.

Authors:  Linyi Chen; Hsin-Yen Cho; Tzu-Hsien Chuang; Ting-Ling Ke; Sheng-Nan Wu
Journal:  Biomedicines       Date:  2022-03-27

5.  p53-Induced Autophagy Regulates Chemotherapy and Radiotherapy Resistance in Multidrug Resistance Cancer Cells.

Authors:  Shumei Ma; Dejuan Kong; Xinxin Fu; Lin Liu; Yi Liu; Chang Xue; Zhujun Tian; Lan Li; Xiaodong Liu
Journal:  Dose Response       Date:  2021-10-08       Impact factor: 2.658

Review 6.  Natural Kinase Inhibitors for the Treatment and Management of Endometrial/Uterine Cancer: Preclinical to Clinical Studies.

Authors:  Rajeev K Singla; Sahar Behzad; Johra Khan; Christos Tsagkaris; Rupesh K Gautam; Rajat Goyal; Hitesh Chopra; Bairong Shen
Journal:  Front Pharmacol       Date:  2022-02-21       Impact factor: 5.810

Review 7.  Ferroptosis: Opportunities and Challenges in Treating Endometrial Cancer.

Authors:  Jianfa Wu; Li Zhang; Suqin Wu; Zhou Liu
Journal:  Front Mol Biosci       Date:  2022-07-01

8.  Effect and mechanisms of kaempferol against endometriosis based on network pharmacology and in vitro experiments.

Authors:  Junde Zhao; Juntao Wang; Jinxing Liu; Shuling Li; Pengfei Liu; Xiaodan Zhang
Journal:  BMC Complement Med Ther       Date:  2022-10-02

9.  Integrative cBioPortal Analysis Revealed Molecular Mechanisms That Regulate EGFR-PI3K-AKT-mTOR Pathway in Diffuse Gliomas of the Brain.

Authors:  Petar Brlek; Anja Kafka; Anja Bukovac; Nives Pećina-Šlaus
Journal:  Cancers (Basel)       Date:  2021-06-29       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.